JPRN-C000000109已完成未知
A Phase II Study of Cisplatin, Etoposide and Concurrent Thoracic Irradiation Followed by Irinotecan and Cisplatin in Patients with Limited Small-Cell Lung Cancer - A Phase II Study of Cisplatin, Etoposide and Concurrent Thoracic Irradiation Followed by Irinotecan and Cisplatin in Patients with Limited Small-Cell Lung Cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Clinically apparent interstitial pneumonitis or pulmonary fibrosis 2. Emphysema, chronic bronchitis or bronchial asthma which precludes thoracic radiotherapy 3. Malignant pleural effusion or malignant pericardial effusion 4. Active concomitant or a recent (<3 years) history of any malignancy 5. Uncontrolled hypertension, unstable angina pectoris, myocardial infarction <3 months before enrollment or congestive heart failure 6. Uncontrolled diabetes mellitus 7. Uncontrolled severe active infection 8. Intestinal paralysis or obstruction 9. Pregnancy or lactation
研究者
相似试验
招募中
2 期
A phase II study of atezolizumab plus chemotherapy for elderly patients with ED-SCLCSmall cell lung cancerJPRN-jRCTs041210002Takahashi Toshiaki40
进行中（未招募）
1 期
Study of Carboplatin, Etoposide, and Atezolizumab With or WithoutTrilaciclib (G1T28) in Patients with Untreated Extensive-Stage Small Cell Lung Cancerntreated Extensive-Stage Small Cell Lung CancerMedDRA version: 21.1Level: PTClassification code 10041068Term: Small cell lung cancer extensive stageSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-000358-20-LVG1 Therapeutics100
进行中（未招募）
1 期
Study of Carboplatin, Etoposide, and Atezolizumab With or WithoutTrilaciclib (G1T28) in Patients with Untreated Extensive-Stage Small Cell Lung CancerEUCTR2017-000358-20-BGG1 Therapeutics100
进行中（未招募）
1 期
Study of Carboplatin, Etoposide, and Atezolizumab With or WithoutTrilaciclib (G1T28) in Patients with Untreated Extensive-Stage Small Cell Lung Cancerntreated Extensive-Stage Small Cell Lung CancerMedDRA version: 21.1Level: PTClassification code 10041068Term: Small cell lung cancer extensive stageSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-000358-20-EEG1 Therapeutics100
进行中（未招募）
1 期
Study of Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28) in Patients with Untreated Extensive-Stage Small Cell Lung CancerEUCTR2017-000358-20-ESG1 Therapeutics100